Association between neutrophil–lymphocyte ratio, socioeconomic status, and ethnic minority with treatment outcome in hepatocellular carcinoma
Yifei Zhang(Hebei Medical University), Rafi Kabarriti(Albert Einstein College of Medicine), N. Patrik Brodin(Albert Einstein College of Medicine), Nitin Ohri, Chandan Guha(Albert Einstein College of Medicine), Santiago Thibaud(Icahn School of Medicine at Mount Sinai), Andreas Kaubisch, Madhur Garg(Albert Einstein College of Medicine), Milan Kinkhabwala(Albert Einstein College of Medicine)
Cited by 9
Related Papers
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
|The Lancet Oncology|2018|2.5k
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19
|JAMA Oncology|2021|186
Rapid and Efficient Genome Editing in <i>Staphylococcus aureus</i> by Using an Engineered CRISPR/Cas9 System
|Journal of the American Chemical Society|2017|148
Characterization and structural basis of a lethal mouse-adapted SARS-CoV-2
|Nature Communications|2021|117